During the past 12 months the Faculty of Biology, Medicine and Health at The University of Manchester  have been working with the Infection, Immunity, Inflammation and Repair (IIIR) Domain, Manchester Academic Health Sciences Centre, teaching and clinical leads to define a strategy for Infectious Diseases Research at Manchester.

The recent work identifies a population of 200+ academics and clinicians having with infection-related research interests which span the entire portfolio of clinical practice in Manchester.

However our proximity, within the Foundation Trust, to one of Europe’s largest Med Micro labs (2 million patient samples per annum) remains largely unexploited and as we move forwards with teaching and research in this field, it would be good to do so in much closer partnership with our clinical and industry colleagues.

In order to fuel this exercise we will be holding a focused meeting on the 9 November 2018 entitled “Hospital- and community-acquired infection”. We would like to invite you to join us and hear presentations from local and international experts in the field.

The agenda will feature talks on HIV and TB infections, rapid point of care diagnostics for CPE, an overview of hospital-acquired-infection (conclusions of the Cochrane review), faecal microbiome transplantation, an overview of activities from the Med Micro laboratory of Manchester Royal Infirmary, new drugs for MDR-Tb, community-acquired hepatitis. We expect a significant industry presence from colleagues at Alderley Park.

Confirmed speakers

• Professor David Perlin (Public Health Research Institute, New Jersey Medical School)
  Hospital outbreaks of Candida auris and CREs (KPC) in the New York region
• Dame Nicky Cullum & Dr Jo Dumville (School of Health Sciences, Manchester)
  Hospital acquired infection: Outcomes of the Cochrane Review
• Dr Simon Smale (Manchester University Foundation Trust)
  Control of C. difficile-associated disease by faecal microbiome transplantation
• Professor Robert Wilkinson (Imperial College London)
  HIV-Tuberculosis, immune interactions
• Dr Timothy Felton (Manchester University Foundation Trust)
  Optimal pharmacotherapy in resistant gram negative infections
• Dr Riina Richardson (Manchester University Foundation Trust
  Role of biofilms in chronic candidiasis
• Professor Lydia Tabernero (University of Manchester)
  Novel drugs for anti-tuberculosis therapy
• Professor Ian Hampson (University of Manchester)
  Mechanisms of viral carcinogenesis
• Professor Ray Borrow (PHE National Meningococcal Reference Unit)
  Development and evaluation of novel meningococcal vaccines
• Dr Kirsty Dodgson (Manchester University Foundation Trust)
  Infection Prevention And Control in The Manchester Foundation Health Trust
• Professor Andrew Fox (PHE Interim Lead Public Health Scientist, NW)
  Public Health Microbiology in the North West